Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Dopamine D2 and D3 receptors inhibit dopamine release.

Tang L, Todd RD, O'Malley KL.

J Pharmacol Exp Ther. 1994 Aug;270(2):475-9.

PMID:
8071839
2.

Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors.

O'Hara CM, Uhland-Smith A, O'Malley KL, Todd RD.

J Pharmacol Exp Ther. 1996 Apr;277(1):186-92.

PMID:
8613917
3.

Pharmacology of high-threshold calcium currents in GH4C1 pituitary cells and their regulation by activation of human D2 and D4 dopamine receptors.

Seabrook GR, Knowles M, Brown N, Myers J, Sinclair H, Patel S, Freedman SB, McAllister G.

Br J Pharmacol. 1994 Jul;112(3):728-34.

4.

D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells.

Chio CL, Drong RF, Riley DT, Gill GS, Slightom JL, Huff RM.

J Biol Chem. 1994 Apr 22;269(16):11813-9.

5.

Morphogenic potentials of D2, D3, and D4 dopamine receptors revealed in transfected neuronal cell lines.

Swarzenski BC, Tang L, Oh YJ, O'Malley KL, Todd RD.

Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):649-53.

6.

Characterization of the functional activity of dopamine ligands at human recombinant dopamine D4 receptors.

Chabert C, Cavegn C, Bernard A, Mills A.

J Neurochem. 1994 Jul;63(1):62-5.

PMID:
7911513
7.
9.

Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines.

Tang L, Todd RD, Heller A, O'Malley KL.

J Pharmacol Exp Ther. 1994 Jan;268(1):495-502. Erratum in: J Pharmacol Exp Ther 1994 Sep;270(3):1397.

PMID:
8301592
10.

Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.

Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E.

J Neurosci. 2002 Apr 1;22(7):2977-88.

11.
13.

In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.

Hidaka K, Tada S, Matsumoto M, Ohmori J, Tasaki Y, Nomura T, Usuda S, Yamaguchi T.

Br J Pharmacol. 1996 Apr;117(8):1625-32.

15.

Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain.

Khan ZU, Gutiérrez A, Martín R, Peñafiel A, Rivera A, De La Calle A.

J Comp Neurol. 1998 Dec 21;402(3):353-71.

PMID:
9853904
16.

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.

Merchant KM, Gill GS, Harris DW, Huff RM, Eaton MJ, Lookingland K, Lutzke BS, Mccall RB, Piercey MF, Schreur PJ, Sethy VH, Smith MW, Svensson KA, Tang AH, Vonvoigtlander PF, Tenbrink RE.

J Pharmacol Exp Ther. 1996 Dec;279(3):1392-403.

PMID:
8968364
17.

Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.

Newman-Tancredi A, Cussac D, Brocco M, Rivet JM, Chaput C, Touzard M, Pasteau V, Millan MJ.

Brain Res. 2001 Nov 30;920(1-2):41-54.

PMID:
11716810
18.

Differential visualization of dopamine D2 and D3 receptors in rat brain.

Parsons B, Stanley M, Javitch J.

Eur J Pharmacol. 1993 Apr 6;234(2-3):269-72.

PMID:
8097723
19.

Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.

L'hirondel M, Chéramy A, Godeheu G, Artaud F, Saiardi A, Borrelli E, Glowinski J.

Brain Res. 1998 May 11;792(2):253-62.

PMID:
9593923
20.

Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat.

Sigala S, Missale C, Spano P.

Eur J Pharmacol. 1997 Oct 8;336(2-3):107-12.

PMID:
9384221

Supplemental Content

Support Center